Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

BACKGROUND: Most patients with malignant peritoneal mesothelioma (MPM) present with late-stage, unresectable disease that responds poorly to systemic chemotherapy while, at the same time, effective targeted therapies are lacking. We assessed the efficacy of cytoreductive surgery (CRS) and hypertherm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Magge, Deepa, Zenati, Mazen S., Austin, Frances, Mavanur, Arun, Sathaiah, Magesh, Ramalingam, Lekshmi, Jones, Heather, Zureikat, Amer H., Holtzman, Matthew, Ahrendt, Steven, Pingpank, James, Zeh, Herbert J., Bartlett, David L., Choudry, Haroon A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100549/
https://ncbi.nlm.nih.gov/pubmed/24322529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3358-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars